Related Experiment Video
Updated: Apr 26, 2026

An R-Based Landscape Validation of a Competing Risk Model
Published on: September 16, 2022
Roadmap to risk evaluation and mitigation strategies (REMS) success
John D Balian1, Janice C Wherry2, Rachpal Malhotra3
1Senior Vice President, Worldwide Safety and Regulatory Operations, Pfizer Medical, Pfizer Inc., New York, NY, USA.
Abstract:
Medical safety-related risk management is a rapidly evolving and increasingly important aspect of drug approval and market longevity. To effectively meet the challenges of this new era, we describe a risk management roadmap that proactively yet practically anticipates risk-management requirements, provides the foundation for enduring yet appropriately flexible risk-management practices, and leverages these techniques to efficiently and effectively utilize risk evaluation and mitigation strategies (REMS)/risk minimization programs as market access enablers. This fully integrated risk-management paradigm creates exciting opportunities for newer tools, techniques, and approaches to more successfully optimize product development, approval, and commercialization, with patients as the ultimate beneficiaries.
Related Concept Videos
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Strategies for Assessing and Addressing Confounding
Confounding can be addressed at both the design phase of a study and through analytical methods after data...
Design Example: Analyzing Capacity Contours for Flood Risk Assessment
Methods of Documentation VI: Case Management Model
For example, a patient with a chronic...
Hazard Rate
Guidelines and Strategies for Safe Computer Charting
Maintain Confidentiality and Security: